Phát hiện các khối u đại trực tràng liên quan bằng PET/CT: độ chính xác hứa hẹn với liều CT tối thiểu và mức cắt chuẩn hóa của PET

Jemal A, Siegel R, Ward E et al (2008) Cancer statistics, 2008. CA Cancer J Clin 58:71–96 Vogelstein B, Fearon ER, Hamilton SR et al (1988) Genetic alterations during colorectal-tumor development. N Engl J Med 319:525–532 Toribara NW, Sleisenger MH (1995) Screening for colorectal cancer. N Engl J Med 332:861–867 Winawer SJ, Zauber AG, Ho MN et al (1993) Prevention of colorectal cancer by colonoscopic polypectomy. The National Polyp Study Workgroup. N Engl J Med 329:1977–1981 Winawer SJ, Fletcher RH, Miller L et al (1997) Colorectal cancer screening: clinical guidelines and rationale. Gastroenterology 112:594–642 Hara AK, Johnson CD, Reed JE et al (1996) Detection of colorectal polyps by computed tomographic colography: feasibility of a novel technique. Gastroenterology 110:284–290 Luboldt W, Bauerfeind P, Steiner P, Fried M, Krestin GP, Debatin JF (1997) Preliminary assessment of three-dimensional magnetic resonance imaging for various colonic disorders. Lancet 349:1288–1291 Levin B, Lieberman DA, McFarland B et al (2008) Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. Gastroenterology 134:1570–1595 Eide TJ (1991) Natural history of adenomas. World J Surg 15:3–6 Nusko G, Mansmann U, Partzsch U et al (1997) Invasive carcinoma in colorectal adenomas: multivariate analysis of patient and adenoma characteristics. Endoscopy 29:626–631 Veit-Haibach P, Kuehle CA, Beyer T et al (2006) Diagnostic accuracy of colorectal cancer staging with whole-body PET/CT colonography. JAMA 296:2590–2600 Nagata K, Ota Y, Okawa T, Endo S, Kudo SE (2008) PET/CT colonography for the preoperative evaluation of the colon proximal to the obstructive colorectal cancer. Dis Colon Rectum 51:882–890 Brenner H, Hoffmeister M, Brenner G, Altenhofen L, Haug U (2009) Expected reduction of colorectal cancer incidence within 8 years after introduction of the German screening colonoscopy programme: estimates based on 1,875,708 screening colonoscopies. Eur J Cancer 14:14 Shen YY, Liang JA, Chen YK, Tsai CY, Kao CH (2006) Clinical impact of 18F-FDG-PET in the suspicion of recurrent colorectal cancer based on asymptomatically elevated serum level of carcinoembryonic antigen (CEA) in Taiwan. Hepatogastroenterology 53:348–350 Vriens D, de Geus-Oei LF, van der Graaf WT, Oyen WJ (2009) Tailoring therapy in colorectal cancer by PET-CT. Q J Nucl Med Mol Imaging 53:224–244 Chen LB, Tong JL, Song HZ, Zhu H, Wang YC (2007) (18)F-DG PET/CT in detection of recurrence and metastasis of colorectal cancer. World J Gastroenterol 13:5025–5029 Sorensen N, Jensen A, Wille-Jorgensen P et al (2009) Strict follow-up programme including CT and F-FDG-PET after curative surgery for colorectal cancer. Colorectal Dis 11:11 Tan E, Gouvas N, Nicholls RJ, Ziprin P, Xynos E, Tekkis PP (2009) Diagnostic precision of carcinoembryonic antigen in the detection of recurrence of colorectal cancer. Surg Oncol 18:15–24 Lim YK, Kam MH, Eu KW (2009) Carcinoembryonic antigen screening: how far should we go? Singapore Med J 50:862–865 Chen YK, Kao CH, Liao AC, Shen YY, Su CT (2003) Colorectal cancer screening in asymptomatic adults: the role of FDG PET scan. Anticancer Res 23:4357–4361 Israel O, Yefremov N, Bar-Shalom R et al (2005) PET/CT detection of unexpected gastrointestinal foci of 18F-FDG uptake: incidence, localization patterns, and clinical significance. J Nucl Med 46:758–762 Gutman F, Alberini JL, Wartski M et al (2005) Incidental colonic focal lesions detected by FDG PET/CT. AJR Am J Roentgenol 185:495–500 Nakajo M, Jinnouchi S, Tashiro Y, Shirahama H, Sato E, Koriyama C (2009) Effect of clinicopathologic factors on visibility of colorectal polyps with FDG PET. AJR Am J Roentgenol 192:754–760 Ravizza D, Bartolomei M, Santoro L et al (2009) Positron emission tomography for the detection of colorectal adenomas. Dig Liver Dis 28:28 Zhuang H, Hickeson M, Chacko TK et al (2002) Incidental detection of colon cancer by FDG positron emission tomography in patients examined for pulmonary nodules. Clin Nucl Med 27:628–632 Agress H Jr, Cooper BZ (2004) Detection of clinically unexpected malignant and premalignant tumors with whole-body FDG PET: histopathologic comparison. Radiology 230:417–422 Kamel EM, Thumshirn M, Truninger K et al (2004) Significance of incidental 18F-FDG accumulations in the gastrointestinal tract in PET/CT: correlation with endoscopic and histopathologic results. J Nucl Med 45:1804–1810 Pandit-Taskar N, Schoder H, Gonen M, Larson SM, Yeung HW (2004) Clinical significance of unexplained abnormal focal FDG uptake in the abdomen during whole-body PET. AJR Am J Roentgenol 183:1143–1147 Even-Sapir E, Lerman H, Gutman M et al (2006) The presentation of malignant tumours and pre-malignant lesions incidentally found on PET-CT. Eur J Nucl Med Mol Imaging 33:541–552 Hemandas AK, Robson NK, Hickish T, Talbot RW (2008) Colorectal tubulovillous adenomas identified on fluoro-2-deoxy-d-glucose positron emission tomography/computed tomography scans. Colorectal Dis 10:386–389 Lee ST, Tan T, Poon AM et al (2008) Role of low-dose, noncontrast computed tomography from integrated positron emission tomography/computed tomography in evaluating incidental 2-deoxy-2-[F-18]fluoro-d-glucose-avid colon lesions. Mol Imaging Biol 10:48–53 Lee JC, Hartnett GF, Hughes BG, Ravi Kumar AS (2009) The segmental distribution and clinical significance of colorectal fluorodeoxyglucose uptake incidentally detected on PET-CT. Nucl Med Commun 30:333–337 Ishimori T, Patel PV, Wahl RL (2005) Detection of unexpected additional primary malignancies with PET/CT. J Nucl Med 46:752–757 Greenlee RT, Murray T, Bolden S, Wingo PA (2000) Cancer statistics, 2000. CA Cancer J Clin 50:7–33 Mansman U, Crispin A, Henschel V et al (2008) Epidemiology and quality control of 245,000 outpatient colonoscopies. Dtsch Arztebl 105:434–440 (www.aerzteblatt-international.de) Edwards JT, Mendelson RM, Fritschi L et al (2004) Colorectal neoplasia screening with CT colonography in average-risk asymptomatic subjects: community-based study. Radiology 230:459–464 Svensson MH, Svensson E, Lasson A, Hellstrom M (2002) Patient acceptance of CT colonography and conventional colonoscopy: prospective comparative study in patients with or suspected of having colorectal disease. Radiology 222:337–345 van Gelder RE, Birnie E, Florie J et al (2004) CT colonography and colonoscopy: assessment of patient preference in a 5-week follow-up study. Radiology 233:328–337 Taylor SA, Halligan S, Saunders BP, Bassett P, Vance M, Bartram CI (2003) Acceptance by patients of multidetector CT colonography compared with barium enema examinations, flexible sigmoidoscopy, and colonoscopy. AJR Am J Roentgenol 181:913–921 Florie J, Birnie E, van Gelder RE et al (2007) MR colonography with limited bowel preparation: patient acceptance compared with that of full-preparation colonoscopy. Radiology 245:150–159 Gluecker TM, Johnson CD, Wilson LA et al (2003) Extracolonic findings at CT colonography: evaluation of prevalence and cost in a screening population. Gastroenterology 124:911–916 Yee J, Kumar NN, Godara S et al (2005) Extracolonic abnormalities discovered incidentally at CT colonography in a male population. Radiology 236:519–526 Pickhardt PJ, Hanson ME, Vanness DJ et al (2008) Unsuspected extracolonic findings at screening CT colonography: clinical and economic impact. Radiology 249:151–159 Pickhardt PJ, Choi JR, Hwang I et al (2003) Computed tomographic virtual colonoscopy to screen for colorectal neoplasia in asymptomatic adults. N Engl J Med 349:2191–2200 Flicker MS, Tsoukas AT, Hazra A, Dachman AH (2008) Economic impact of extracolonic findings at computed tomographic colonography. J Comput Assist Tomogr 32:497–503 Hara AK, Johnson CD, MacCarty RL, Welch TJ (2000) Incidental extracolonic findings at CT colonography. Radiology 215:353–357 Yasuda S, Fujii H, Nakahara T et al (2001) 18F-FDG PET detection of colonic adenomas. J Nucl Med 42:989–892 van Kouwen MC, Nagengast FM, Jansen JB, Oyen WJ, Drenth JP (2005) 2-(18F)-fluoro-2-deoxy-d-glucose positron emission tomography detects clinical relevant adenomas of the colon: a prospective study. J Clin Oncol 23:3713–3717 Friedland S, Soetikno R, Carlisle M, Taur A, Kaltenbach T, Segall G (2005) 18-Fluorodeoxyglucose positron emission tomography has limited sensitivity for colonic adenoma and early stage colon cancer. Gastrointest Endosc 61:395–400 van Kouwen MC, Drenth JP, van Krieken JH et al (2006) Ability of FDG-PET to detect all cancers in patients with familial adenomatous polyposis, and impact on clinical management. Eur J Nucl Med Mol Imaging 33:270–274 Truijers M, Pol JA, Kurvers H, Bredie S, Oyen WJ, Blankensteijn JD (2009) Incidental finding of malignancy in patients preoperatively evaluated for aneurysm wall pathology using PET/CT. J Vasc Surg 49:1313–1315 Choi JY, Lee KS, Kwon OJ et al (2005) Improved detection of second primary cancer using integrated [18F] fluorodeoxyglucose positron emission tomography and computed tomography for initial tumor staging. J Clin Oncol 23:7654–7659 Yapar Z, Kibar M, Yapar AF et al (2010) The value of 18F-fluorodeoxyglucose positron emission tomography/computed tomography in carcinoma of an unknown primary: diagnosis and follow-up. Nucl Med Commun 31:59–66 Yasuda S, Ide M, Fujii H et al (2000) Application of positron emission tomography imaging to cancer screening. Br J Cancer 83:1607–1611 Shen YY, Su CT, Chen GJ, Chen YK, Liao AC, Tsai FS (2003) The value of 18F-fluorodeoxyglucose positron emission tomography with the additional help of tumor markers in cancer screening. Neoplasma 50:217–221 Chen YK, Ding HJ, Su CT et al (2004) Application of PET and PET/CT imaging for cancer screening. Anticancer Res 24:4103–4108 Ide M (2006) Cancer screening with FDG-PET. Q J Nucl Med Mol Imaging 50:23–27 Minamimoto R, Senda M, Uno K et al (2007) Performance profile of FDG-PET and PET/CT for cancer screening on the basis of a Japanese nationwide survey. Ann Nucl Med 21:481–498 Kojima S, Zhou B, Teramukai S et al (2007) Cancer screening of healthy volunteers using whole-body 18F-FDG-PET scans: the Nishidai clinic study. Eur J Cancer 43:1842–1848 Nishizawa S, Kojima S, Teramukai S et al (2009) Prospective evaluation of whole-body cancer screening with multiple modalities including [18F]fluorodeoxyglucose positron emission tomography in a healthy population: a preliminary report. J Clin Oncol 27:1767–1773 Hays MT, Watson EE, Thomas SR, Stabin M (2002) MIRD dose estimate report no. 19: radiation absorbed dose estimates from (18)F-FDG. J Nucl Med 43:210–214 Becker N, Wahrendorf J (1998) Krebsatlas der Bundesrepublik Deutschland 1981–1990. Springer, Berlin. http://www.dkfz-heidelberg.de/de/krebsatlas/gesamt/mort_2.html. Accessed 24 Sept 2009 Otsuka H, Graham MM, Kubo A, Nishitani H (2005) The effect of oral contrast on large bowel activity in FDG-PET/CT. Ann Nucl Med 19:101–108 Boellaard R, Oyen WJ, Hoekstra CJ et al (2008) The Netherlands protocol for standardisation and quantification of FDG whole body PET studies in multi-centre trials. Eur J Nucl Med Mol Imaging 35:2320–2333 Paquet N, Albert A, Foidart J, Hustinx R (2004) Within-patient variability of (18)F-FDG: standardized uptake values in normal tissues. J Nucl Med 45:784–788 Hassan C, Pickhardt PJ, Laghi A et al (2009) Impact of whole-body CT screening on the cost-effectiveness of CT colonography. Radiology 251:156–165